BERGAPTEN FROM LEUCAS URTICIFOLIA MITIGATES ISOPROTERENOL-INDUCED CARDIOTOXICITY THROUGH NRF2/HO-1 SIGNALLING PATHWAY

Authors

  • NEMALAPALLI YAMINI Department of Pharmacology, Jawaharlal Nehru Technological University-Oil Technological and Pharmaceutical Research Institute, Anantapur, Andhra Pradesh, India. https://orcid.org/0000-0001-8333-0643
  • JUTURU MASTANAIAH Department of Pharmacology, Balaji College of Pharmacy, Anantapur, Andhra Pradesh, India. https://orcid.org/0000-0003-0374-2248

DOI:

https://doi.org/10.22159/ajpcr.2026v19i3.57402

Keywords:

Isoproterenol, Leucas urticifolia, Gas chromatography-mass spectrometry, Cardiac markers

Abstract

Objective :.This study evaluated whether an ethanolic extract of Leucas urticifolia(ELU) attenuates isoproterenol-induced cardiac damage in Wistar rats.

Method: The cardioprotective potential of ELU was assessed using in vitro and in vivo experiments, and its bioactive component bergapten was identified using GC-MS and quantified by RPHPLC.The safety profile and effects of ELU (50 and 100 mg/kg) on cardiac biomarkers, lipid profiles, oxidative stress markers, inflammatory cytokines, Nrf2/Keap1/HO-1 pathway, and cardiac histopathology were evaluated in experimental rats.

Results: ELU showed significant tissue antioxidant activity, no substantial cytotoxicity in H9C2 cells (IC₅₀: 82.04 µg/mL), and was safe in acute oral toxicity studies up to 2000 mg/kg in rats. ELU significantly reduced the levels of cardiac biomarkers, including creatine kinase-MB, lactate dehydrogenase, and cardiac troponin T. ELU also enhanced myocardial antioxidant enzyme activity and decreased malondialdehyde levels.ELU downregulated the inflammatory mediators TNF-α, IL-1β, IL-6, NF-κB, and C-reactive protein, while upregulating anti-inflammatory interleukin-10.Gene expression and western blot analysis showed that ELU restored redox homeostasis by activating the Nrf2/HO-1 antioxidant axis and suppressing Keap1 expression in a dose-dependent manner.Histopathological analysis confirmed cardiac architecture preservation in the ELU-treated groups.

Conclusion: ELU exerts cardioprotective effects by attenuating oxidative stress, suppressing inflammation, reactivating Nrf2 signalling, and minimizing myocardial injury in ISO-induced MI in Wistar rats, supporting its development as a natural cardioprotective agent and providing a rationale for further investigations.

Downloads

Download data is not yet available.

References

1. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol. 2022;80(25):2361-71. doi: 10.1016/j. jacc.2022.11.005, PMID 36368511

2. Reddy K, Khaliq A, Henning RJ. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol. 2015;7(5):243-76. doi: 10.4330/wjc.v7.i5.243, PMID 26015857

3. Nugraheni K, Saputri FC. The effect of secang extract (Caesalpinia sappan Linn) on the weight and histology appearance of white male rats’ hearts induced by isoproterenol. Int J App Pharm. 2017;9 Suppl 1:59. doi: 10.22159/ijap.2017.v9s1.35_41

4. Gaziano T, Reddy KS, Paccaud F, Horton S, Chaturvedi V, Jamison DT, et al. Cardiovascular disease. In: Disease Control Priorities in Developing Countries. Washington, DC: The International Bank for Reconstruction and Development; 2006.

5. Aliyev H, Bilgili S, Toktay E, Nuriyeva N, Bayir Y. Protective effects of oxyresveratrol in isoproterenol-induced myocardial infarction in rats: A stereological study. Eurasian J Med. 2025;57(1):e23214. doi: 10.5152/eurasianjmed.2024.23214

6. Ekici M, Güngör H, Karayığıt MÖ, Turgut NH, Koҫkaya M, Karataș Ö, et al. Cardioprotective effect of empagliflozin in ratswith isoproterenol-induced myocardial infarction: Evaluation of lipid profile, oxidative stress, inflammation, DNA damage, and apoptosis. Biol Bull. 2022;49(S1):S159-72. doi: 10.1134/S1062359022130039

7. Ullah S, Ahmad T, Ikram M, Rasheed HM, Khan MI, Khan T, et al. 7-hydroxy frullanolide ameliorates isoproterenol-induced myocardial injury through modification of iNOS and Nrf2 genes. Biomedicines. 2023;11(9):2470. doi: 10.3390/biomedicines11092470, PMID 37760913

8. Chouhan HS, Singh SK. A review of plants of genus Leucas. J Pharmacogn Phytother. 2011;3:13-26.

9. Das SN, Patro VJ, Dinda SC. A review: Ethnobotanical survey of genus Leucas. Pharmacogn Rev. 2012;6(12):100-6. doi: 10.4103/0973- 7847.99943, PMID 23055635

10. Atia-tun-Noor I, Fatima I, Ahmad I, Malik A, Afza N, Iqbal L, et al. Leufolins A and B, potent butyrylcholinesterase-inhibiting flavonoid glucosides from Leucas urticifolia. Molecules. 2007;12(7):1447-54. doi: 10.3390/12071447, PMID 17909500

11. Fatima I, Ahmad I, Anis I, Malik A, Afza N, Iqbal L, et al. New butyrylcholinesterase inhibitory steroid and peroxy acid from Leucas urticifolia. Arch Pharm Res. 2008;31(8):999-1003. doi: 10.1007/ s12272-001-1259-5, PMID 18787788

12. Assyfa A, Dalimunthe A. Phytochemical analysis and antioxidant activity of methanol extract of Zanthoxylum acanthopodium DC. fruits using CUPRAC methods. Int J Appl Pharm. 2024;16 Special Issue 4:34-7. doi: 10.22159/ijap.2024.v16s4.05

13. Senthil K, Thirugnanasambantham P, Oh TJ, Kim SH, Choi HK. Free radical scavenging activity and comparative metabolic profiling of in vitro cultured and field-grown Withania somnifera roots. PLoS One. 2015;10(4):e0123360. doi: 10.1371/journal.pone.0123360, PMID 25874568

14. Katekhaye SD, Laddha KS. Microwave-assisted extraction and RP-HPLC quantification of bergapten from Pithecellobium dulce. Indian J Pharm Sci. 2016;78(5):167-72. doi: 10.4172/pharmaceutical-sciences.1000167

15. Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221-47. doi: 10.1007/s00018-016-2223-0, PMID 27100828

16. Nelson VK, Sahoo NK, Sahu M, Sudhan HH, Pullaiah CP, Muralikrishna KS. In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116. BMC Complement Med Ther. 2020;20(1):355. doi: 10.1186/s12906-020-03118-9, PMID 33225921

17. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170-5. doi: 10.1016/S0021-9258(19)45228-9, PMID 4623845

18. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. Weinheim/New York: Verlag Chemie/Academic Press Inc.; 1974. p. 673-84. doi: 10.1016/B978-0-12-091302-2.50032-3

19. Kovachich GB, Mishra OP. Lipid peroxidation in rat brain cortical slices as measured by the thiobarbituric acid test. J Neurochem. 1980;35(6):1449-52. doi: 10.1111/j.1471-4159.1980.tb09022.x, PMID 7441260

20. Refaie MM, Shehata S, Ibrahim RA, Bayoumi AM, Abdel-Gaber SA. Dose-dependent cardioprotective effect of hemin in doxorubicin-induced cardiotoxicity via Nrf-2/HO-1 and TLR-5/NF-κB/TNF-α signaling pathways. Cardiovasc Toxicol. 2021;21(12):1033-44. doi: 10.1007/s12012-021-09694-7, PMID 34510376

21. Kashyap VK, Srivastava P, Hedaytullah MD, Alam S. Cardioprotective effect of Trikatu churna on isoproterenol-induced myocardial infarction. Int J Pharm Pharm Sci. 2024;16(2):24-9. doi: 10.22159/ ijpps.2024v16i2.49824

22. Hartikainen T, Sörensen N, Haller P, Goßling A, Lehmacher J, Zeller T, et al. Acute myocardial infarction. Eur Heart J. 2023;41:2209-16.

23. Li L, Cai W, Zhang H, Tang J, Yang Y, Huang Y, et al. Bergapten ameliorates renal fibrosis by inhibiting ferroptosis. Phytother Res. 2025;39(3):1355-71. doi: 10.1002/ptr.8425, PMID 39764683

24. Fazeela MB, Sankarram M. Phytochemical characterization by GC-MS and in vitro evaluation of antiproliferative and antimigratory studies of Leucas aspera leaf extracts on MDA-MB-231 cell line. Biotechnologia. 2024;105(1):55-68. doi: 10.5114/bta.2024.135642, PMID 38633889

25. Nutan R, Veena S. Phytochemical analysis of Leucas urticifolia (Vahl) R. Br. ex Sm.: A traditional medicinal herb. J Pharmacogn Phytochem. 2019;8:1752-6.

26. Garg M, Khanna D. Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models. Ther Adv Cardiovasc Dis. 2014;8(4):155-69. doi: 10.1177/1753944714531638, PMID 24817146

27. Pullaiah CP, Narasimha Kumar GV, Jyothsna K, Thyagaraju K, Nelson VK, Dayanand Reddy G. Rosa damascena Mill. L. attenuates myocardial lysosomal membrane destabilization in isoproterenol-induced oxidative stress. Orient Pharm Exp Med. 2017;17(4):373-80. doi: 10.1007/s13596-017-0290-x

28. Sun K, Li YY, Jin J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal Transduct Target Ther. 2021;6(1):79. doi: 10.1038/s41392-020-00455-6, PMID 33612829

29. Yu B, Wang W. Cardioprotective effects of morroniside in rats following acute myocardial infarction. Inflammation. 2018;41(2):432-6. doi: 10.1007/s10753-017-0699-x, PMID 29168080

30. Muro P, Zhang L, Li S, Zhao Z, Jin T, Mao F, et al. The emerging role of oxidative stress in inflammatory bowel disease. Front Endocrinol (Lausanne). 2024;15:1390351. doi: 10.3389/fendo.2024.1390351, PMID 39076514

31. Mohsin N, Akhtar MS, Alkahtani SA, Walbi IA, Alhazmi Y, Alam MN, et al. Nephroprotective effect of bergapten against cyclophosphamide-mediated renal stress, inflammation, and fibrosis in Wistar rats: Probable role of NF-kB and TGF-β1 signaling molecules. ACS Omega. 2024;9(16):18296-303. doi: 10.1021/acsomega.4c00124, PMID 38680299

32. Kripa KG, Chamundeeswari D, Thanka J, Uma Maheswara Reddy C. Modulation of inflammatory markers by the ethanolic extract of Leucas aspera in adjuvant arthritis. J Ethnopharmacol. 2011;134(3):1024-7. doi: 10.1016/j.jep.2011.01.010, PMID 21251972

33. Pullaiah CP, Nelson VK, Rayapu S, G NK, Kedam T. Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: In vivo and in vitro evidence. BMC Pharmacol Toxicol. 2021;22(1):43. doi: 10.1186/s40360-021-00510-0, PMID 34266475

34. Dixit V, Irshad S, Agnihotri P, Paliwal AK, Husain T. Evaluation of antioxidant and antimicrobial potential of Leucas urticaefolia (Lamiaceae). J Appl Pharm Sci. 2015;5:39-45. doi: 10.7324/ JAPS.2015.54.S7

35. Latif K, Khan AU, Izhar Ul Haque M, Naeem K. Bergapten attenuates nitroglycerin-induced migraine headaches through inhibition of oxidative stress and inflammatory mediators. ACS Chem Neurosci. 2021;12(18):3303-13. doi: 10.1021/acschemneuro.1c00146, PMID 34455773

36. Singh G, Kaur A, Kaur J, Bhatti MS, Singh P, Bhatti R. Bergapten inhibits chemically induced nociceptive behavior and inflammation in mice by decreasing the expression of spinal PARP, iNOS, COX-2 and inflammatory cytokines. Inflammopharmacology. 2019;27(4):749-60. doi: 10.1007/s10787-019-00585-6, PMID 30953227

37. Zhou Y, Wang J, Yang W, Qi X, Lan L, Luo L, et al. Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge. Int Immunopharmacol. 2017;48:159-68. doi: 10.1016/j.intimp.2017.04.026, PMID 28511114

38. Xiang Q, Zhao Y, Lin J, Jiang S, Li W. The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights. Exp Mol Med. 2022;54(8):1067-75. doi: 10.1038/s12276-022-00829-6, PMID 35978054

39. Kowalczyk J, Kurach Ł, Boguszewska-Czubara A, Skalicka- Woźniak K, Kruk-Słomka M, Kurzepa J, et al. Bergapten improves scopolamine-induced memory impairment in mice via cholinergic and antioxidative mechanisms. Front Neurosci. 2020;14:730. doi: 10.3389/ fnins.2020.00730, PMID 32903765

40. Yang Y, Han J, Lilly RG, Yang Q, Guo Y. Bergapten mediated inflammatory and apoptosis through AMPK/eNOS/AKT signaling pathway of isoproterenol-induced myocardial infarction in Wistar rats. J Biochem Mol Toxicol. 2022;36(9):e23143. doi: 10.1002/jbt.23143, PMID 35815753

Published

07-03-2026

How to Cite

NEMALAPALLI YAMINI, and JUTURU MASTANAIAH. “BERGAPTEN FROM LEUCAS URTICIFOLIA MITIGATES ISOPROTERENOL-INDUCED CARDIOTOXICITY THROUGH NRF2 HO-1 SIGNALLING PATHWAY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 19, no. 3, Mar. 2026, pp. 144-53, doi:10.22159/ajpcr.2026v19i3.57402.

Issue

Section

Original Article(s)